Belgium Advances Cervical Cancer Prevention with HPV-Based Screening

cervical cancer prevention

Belgium Advances Cervical Cancer Prevention with HPV-Based Screening Transitioning from Pap test screening to primary HPV-based screening Belgium Advances Cervical Cancer Prevention with HPV-Based Screening Brussels, Belgium — Effective 1 January 2025, Belgium has officially transitioned from cytology-based (Pap test) screening to primary HPV-based screening for cervical cancer. This marks a major advancement in evidence-based […]

Toward Lung Cancer Screening in France: The IMPULSION Pilot Program

Toward Lung Cancer Screening in France The IMPULSION Pilot Program

Toward Lung Cancer Screening in France The IMPULSION Pilot Program   Lung cancer remains the leading cause of cancer-related mortality in France, with 30,900 deaths recorded in 2022. Tobacco use is responsible for nearly 80% of diagnosed cases.   In 2022, the Haute Autorité de Santé recommended the launch of a pilot program using low-dose […]

National Cervical Cancer Screening Program in France: Progress and Challenges

National Cervical Cancer Screening Program in France Progress and Challenges

National Cervical Cancer Screening Program in France Progress and Challenges National Cervical Cancer Screening Program in France   Established in 2018, the National Cervical Cancer Screening Program targets all women aged 25 to 65, including pregnant women, postmenopausal women, and women vaccinated against Human Papillomavirus (HPV). Each year, over 10 million women benefit from this […]

Organized Colorectal Cancer Screening Program: Trends, Access, and Innovations

Organized Colorectal Cancer Screening Program

Organized Colorectal Cancer Screening Program Trends, Access, and Innovations Colorectal Cancer Screening Program Launched in 2010, the French National Organized Colorectal Cancer Screening Program aims to reduce mortality from colorectal cancer through early detection and timely treatment of precancerous lesions. The participation rate was of 32.1% during the 2010-2011 period, and 29.6% in 2023-2024, a […]

Organized Breast Cancer Screening Program in France: Participation Trends and Perspectives

Organized Breast Cancer Screening Program in France Participation Trends and Perspectives

Organized Breast Cancer Screening Program in France Participation Trends and Perspectives Organized Breast Cancer Screening Program in France Organized breast cancer screening was rolled out in France in 2004. Aimed at detecting the most common and deadliest cancer among women, the program has experienced a gradual decline in participation rates over the past decade, across […]

Modern prevention in action: Hungary’s expanding role in lung cancer screening

lung cancer screening

Modern prevention in action – Hungary’s expanding role in lung cancer screening Hungary continues to strenghen its effort on lung cancer prevention with the progressive expansion of its low-dose computed tomography (LDCT) screening programme. Lung Cancer Screening Building on the success of earlier pilot studies, the country is now testing population-level solutions with a focus […]

Integrating Excellence: A Methodological Hub for Lung Cancer Solutions

Integrating Excellence A Methodological Hub for Lung Cancer Solutions

Integrating Excellence: A Methodological Hub for Lung Cancer Solutions NKIP Lung cancer remains one of the most serious public health challenges across Europe, but progress is being made—thanks to institutions like Hungary’s National Korányi Institute for Pulmonology (NKIP). With over a century of expertise and a future-focused approach, the institute stands at the crossroads of […]

Organized Cervical Cancer Screening Program in Hungary

thermal ablator for cervical precancer treatment

Organized Cervical Cancer Screening Program in Hungary Since 2003, Hungary has operated an organized, population-based cervical cancer screening program aimed at the early detection and prevention of cervical cancer. The program targets women aged 25 to 65, who receive a personalized invitation letter every three years to attend the screening. The primary method of examination […]